NDC 69238-2095 – Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC69238-2095

Product details

Brand name
Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Amneal Pharmaceuticals NY LLC
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA209721
Marketed since
August 26, 2018
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
69238-2095-330 TABLET, FILM COATED in 1 BOTTLE (69238-2095-3)Aug 26, 2018

Other Emtricitabine and tenofovir disoproxil fumarate products